BioDlink International Company Limited (HKG:1875)
Hong Kong · Delayed Price · Currency is HKD 3.270
-0.020 (-0.61%)
Jun 18, 2026, 10:07 AM HKT
HKG:1875 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 747.65 | 1,098 | 780.63 | 442.18 | 76.33 | |
Revenue Growth (YoY) | -31.93% | 40.70% | 76.54% | 479.34% | 239.36% |
Cost of Revenue | 358.67 | 315.9 | 206.64 | 71.56 | 48.85 |
Gross Profit | 388.98 | 782.43 | 573.99 | 370.62 | 27.47 |
Selling, General & Admin | 401.58 | 688.09 | 509.33 | 266.54 | 79.19 |
Research & Development | 85.68 | 79.31 | 103.89 | 151.17 | 214.7 |
Other Operating Expenses | -21.7 | -23.12 | -17.88 | -8.76 | -10.95 |
Operating Expenses | 469.47 | 745.32 | 595.03 | 409.55 | 282.93 |
Operating Income | -80.49 | 37.11 | -21.04 | -38.93 | -255.46 |
Interest Expense | -11.92 | -9.88 | -5.18 | -6.6 | -2.47 |
Interest & Investment Income | 2.25 | 3.38 | 2.97 | 2.27 | 0.97 |
Earnings From Equity Investments | - | - | -2.5 | -6.63 | -0.02 |
Currency Exchange Gain (Loss) | -1.6 | -3.97 | 2.26 | 1.3 | 1.24 |
Other Non Operating Income (Expenses) | 0.28 | 9.05 | -11.8 | - | - |
EBT Excluding Unusual Items | -91.48 | 35.69 | -35.27 | -48.6 | -255.73 |
Gain (Loss) on Sale of Investments | - | - | 0.94 | 0.91 | - |
Gain (Loss) on Sale of Assets | -0.14 | -0.93 | -3.42 | -2.36 | -5.49 |
Asset Writedown | -8.75 | - | - | - | - |
Pretax Income | -100.37 | 34.76 | -37.76 | -50.05 | -261.22 |
Income Tax Expense | - | - | 0 | - | - |
Earnings From Continuing Operations | -100.37 | 34.76 | -37.76 | -50.05 | -261.22 |
Minority Interest in Earnings | - | - | - | 0.13 | - |
Net Income | -100.37 | 34.76 | -37.76 | -49.92 | -261.22 |
Net Income to Common | -100.37 | 34.76 | -37.76 | -49.92 | -261.22 |
Shares Outstanding (Basic) | 725 | 725 | 725 | 639 | 573 |
Shares Outstanding (Diluted) | 725 | 725 | 725 | 639 | 573 |
Shares Change (YoY) | - | - | 13.44% | 11.50% | 0.53% |
EPS (Basic) | -0.14 | 0.05 | -0.05 | -0.08 | -0.46 |
EPS (Diluted) | -0.14 | 0.05 | -0.05 | -0.08 | -0.46 |
Free Cash Flow | -19.63 | -6.39 | -140.85 | -179.05 | -287.42 |
Free Cash Flow Per Share | -0.03 | -0.01 | -0.19 | -0.28 | -0.50 |
Gross Margin | 52.03% | 71.24% | 73.53% | 83.82% | 36.00% |
Operating Margin | -10.76% | 3.38% | -2.70% | -8.80% | -334.70% |
Profit Margin | -13.43% | 3.16% | -4.84% | -11.29% | -342.24% |
Free Cash Flow Margin | -2.63% | -0.58% | -18.04% | -40.49% | -376.57% |
EBITDA | -6.44 | 98.28 | 17.76 | -4.43 | -224.2 |
EBITDA Margin | -0.86% | 8.95% | 2.27% | -1.00% | -293.75% |
D&A For EBITDA | 74.05 | 61.18 | 38.8 | 34.5 | 31.25 |
EBIT | -80.49 | 37.11 | -21.04 | -38.93 | -255.46 |
EBIT Margin | -10.76% | 3.38% | -2.70% | -8.80% | - |
Advertising Expenses | 308.26 | 587.12 | 428.46 | 195.93 | 1.22 |